Pledging ‘Radical Transparency,’ FDA Reveals Drug Rejection Letters — With Limits
The FDA published more than 200 complete response letters, the first step in what it…
Pledging ‘Radical Transparency,’ FDA Reveals Drug Rejection Letters — With Limits
The FDA published more than 200 complete response letters, the first step in what it describes as part of its effort to modernize the agency and improve transparency. But there are some caveats to the release of the FDA correspondence. The post Pledging ‘Radical Transparency,’ FDA Reveals Drug Rejection Letters — With Limits appeared first…
Women’s Health Company Tia Health Launches Longevity Service Line
Tia Health recently launched its longevity service line, which is starting with a focus on heart health. It includes labs and one-on-one provider guidance. The post Women’s Health Company Tia Health Launches Longevity Service Line appeared first on MedCity News.
Better Navigation is Key to Improving Behavioral Health Access and Outcomes
The promise of current and future technologies is encouraging – and it further underscores the importance of building the right support systems to help patients navigate the system and access the appropriate care at the right time and place. The post Better Navigation is Key to Improving Behavioral Health Access and Outcomes appeared first on…
Healthcare’s Tariff Conundrum: Mitigating Supply Chain Risks with Data and Relationships
Improving the outlook starts with a better supply chain model — one that shifts from a transactional to strategic focus and is built on collaborative supplier models and more domestic sourcing. The post Healthcare’s Tariff Conundrum: Mitigating Supply Chain Risks with Data and Relationships appeared first on MedCity News.
GLP-1s, Personalization, and Big Pharma Power Plays: What’s Really at Stake in the Eli Lilly Lawsuit
This lawsuit may look like a business dispute on the surface. But underneath, it’s about something much more important: the right of patients to receive personalized, affordable care. The post GLP-1s, Personalization, and Big Pharma Power Plays: What’s Really at Stake in the Eli Lilly Lawsuit appeared first on MedCity News.
Journalists Tally State and Local Health Care Implications of GOP Megabill
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed measles cases on CBS News’ “CBS News 24/7” on July 9. Gounder also discussed the presence of Immigration and Customs Enforcement in medical facilities on CBS News’ “CBS Mornings Plus” on July 8. Click here to watch Gounder on “CBS News 24/7.” Click here to watch…
Trump Team’s Actions on Health Policy Clash With Its ‘MAHA Report’
The Trump administration recently issued a manifesto on what’s wrong with health in America, but many of its actions clash with its answers. Scientists and public health advocates see deep disconnects between what the administration has said about health — notably, in “The MAHA Report,” which President Donald Trump recently presented at the White House…
New Legislation Seeks to Preserve Hospital-at-Home Reimbursement Until 2030
A bipartisan group of lawmakers introduced legislation this week to extend CMS’ hospital-at-home waiver for five more years, allowing hospitals to continue delivering acute care in patients’ homes with Medicare reimbursement. The move comes as research shows this model reduces mortality and healthcare costs. The post New Legislation Seeks to Preserve Hospital-at-Home Reimbursement Until 2030…
FDA Turns Down Capricor Cell Therapy for Cardio Complications of Rare Muscle Disease
Capricor Therapeutics said the FDA asked for more data supporting the efficacy of Deramiocel, the biotech’s off-the-shelf cell therapy for treating the heart complications of Duchenne muscular dystrophy. Those data could come from an ongoing Phase 3 study expected to yield preliminary data soon. The post FDA Turns Down Capricor Cell Therapy for Cardio Complications…
